Oscar Health, Inc. - Laporan Laba Rugi (TTM)

Oscar Health, Inc.
US ˙ NYSE ˙ US6877931096

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Oscar Health, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 391 682 1,096 1,439 1,894 2,491 2,983 3,519 3,964 4,482 4,982 5,437 5,863 6,535 7,233 8,215 9,178 10,082 10,726
Change (%) 74.38 60.81 31.27 31.59 31.52 19.74 17.98 12.63 13.09 11.15 9.13 7.83 11.47 10.68 13.58 11.71 9.85 6.39
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 309 493 858 1,226 1,624 2,091 2,479 2,878 3,281 3,638 4,011 4,322 4,642 5,105 5,632 6,473 7,333 8,037 8,882
Change (%) 59.42 73.88 42.93 32.49 28.73 18.60 16.10 13.98 10.88 10.26 7.74 7.41 9.98 10.32 14.93 13.28 9.61 10.50
% of Revenue 79.12 72.34 78.21 85.16 85.74 83.92 83.12 81.79 82.77 81.16 80.51 79.49 79.18 78.12 77.86 78.79 79.90 79.72 82.80
Gross Operating Profit 82 189 239 214 270 401 503 641 683 845 971 1,115 1,221 1,430 1,601 1,743 1,845 2,044 1,844
Change (%) 131.05 26.65 -10.59 26.44 48.33 25.69 27.25 6.58 23.68 14.96 14.89 9.45 17.16 11.96 8.81 5.88 10.79 -9.77
% of Revenue 20.88 27.66 21.79 14.84 14.26 16.08 16.88 18.21 17.23 18.84 19.49 20.51 20.82 21.88 22.14 21.21 20.10 20.28 17.20
SG&A 267 304 351 365 446 466 521 607 1,257 884 1,013 1,176 1,379 1,375 1,519 971 1,756 1,844 1,943
Change (%) 13.52 15.53 4.21 22.18 4.33 11.81 16.52 107.21 -29.72 14.60 16.12 17.31 -0.32 10.49 -36.12 80.87 5.05 5.38
% of Revenue 68.38 44.52 31.98 25.39 23.57 18.70 17.46 17.24 31.72 19.72 20.33 21.63 23.53 21.04 21.01 11.82 19.13 18.29 18.12
R&D
Change (%)
% of Revenue
OpEx 793 1,052 1,500 1,974 2,439 3,039 3,565 4,082 4,554 5,029 5,383 5,703 6,052 6,514 7,184 8,202 9,120 9,913 10,856
Change (%) 32.64 42.56 31.63 23.51 24.63 17.30 14.50 11.56 10.44 7.03 5.96 6.12 7.63 10.28 14.18 11.20 8.69 9.51
% of Revenue 202.89 154.32 136.80 137.17 128.75 122.00 119.51 115.99 114.88 112.20 108.04 104.90 103.23 99.67 99.31 99.84 99.38 98.33 101.21
Operating Income -402 -370 -404 -535 -544 -548 -582 -563 -590 -547 -400 -266 -189 22 50 13 57 169 -129
Change (%) -7.93 8.95 32.60 1.76 0.66 6.20 -3.32 4.82 -7.32 -26.75 -33.49 -28.91 -111.41 129.77 -73.38 333.20 194.82 -176.68
% of Revenue -102.89 -54.32 -36.80 -37.17 -28.75 -22.00 -19.51 -15.99 -14.88 -12.20 -8.04 -4.90 -3.23 0.33 0.69 0.16 0.62 1.67 -1.21
Interest Expense -4 -7 -7 -8 -5 -5 -11 -17 -23 -25 -25 -25 -25 -24 -24 -24 -24 -24 -24
Change (%) 105.21 3.16 5.35 -39.77 11.10 112.76 51.34 33.98 8.46 -0.09 0.02 0.33 -0.95 -0.53 -1.30 -0.80 0.39 -0.60
% of Revenue -0.90 -1.06 -0.68 -0.54 -0.25 -0.21 -0.37 -0.48 -0.57 -0.55 -0.49 -0.45 -0.42 -0.37 -0.34 -0.29 -0.26 -0.24 -0.22
Net Income -407 -399 -431 -564 -573 -559 -598 -579 -606 -571 -474 -347 -271 -54 18 29 25 123 -161
Change (%) -1.97 8.12 30.69 1.61 -2.40 6.95 -3.11 4.68 -5.84 -16.93 -26.89 -21.92 -80.21 -133.86 59.52 -12.15 384.96 -230.73
% of Revenue -104.05 -58.50 -39.33 -39.15 -30.23 -22.44 -20.04 -16.46 -15.30 -12.74 -9.52 -6.38 -4.62 -0.82 0.25 0.35 0.28 1.22 -1.50

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista